Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma A Mol

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Advanced Drug Delivery Reviews|March 2, 2016
Extracellular vesicles for drug deliveryPieter Vader, Emma A Mol, Gerard Pasterkamp, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 3, 2017
Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugationEmma A Mol, Marie-José Goumans, Pieter A Doevendans, et al.
Cells|November 29, 2019
Biofabrication of Cell-Derived Nanovesicles: A Potential Alternative to Extracellular Vesicles for Regenerative MedicineNazma F Ilahibaks, Zhiyong Lei, Emma A Mol, et al.
Advanced Healthcare Materials|September 28, 2019
Injectable Supramolecular Ureidopyrimidinone Hydrogels Provide Sustained Release of Extracellular Vesicle TherapeuticsEmma A Mol, Zhiyong Lei, Marieke T Roefs, et al.
Advanced Therapeutics|September 24, 2019
Decellularized Extracellular Matrix Hydrogels as a Delivery Platform for MicroRNA and Extracellular Vesicle TherapeuticsMelissa J Hernandez, Roberto Gaetani, Vera M Pieters, et al.
Plos One|January 1, 2020
Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failurePatricia van den Hoogen, Saskia C A de Jager, Emma A Mol, et al.
Frontiers in Cardiovascular Medicine|May 14, 2019
Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac FibrosisTom C L Bracco Gartner, Janine C Deddens, Emma A Mol, et al.
Advanced Healthcare Materials|August 30, 2016
Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRINKrijn R Vrijsen, Janita A Maring, Steven A J Chamuleau, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|March 2, 2016
Extracellular vesicles for drug deliveryPieter Vader, Emma A Mol, Gerard Pasterkamp, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 3, 2017
Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugationEmma A Mol, Marie-José Goumans, Pieter A Doevendans, et al.
Cells|November 29, 2019
Biofabrication of Cell-Derived Nanovesicles: A Potential Alternative to Extracellular Vesicles for Regenerative MedicineNazma F Ilahibaks, Zhiyong Lei, Emma A Mol, et al.
Advanced Healthcare Materials|September 28, 2019
Injectable Supramolecular Ureidopyrimidinone Hydrogels Provide Sustained Release of Extracellular Vesicle TherapeuticsEmma A Mol, Zhiyong Lei, Marieke T Roefs, et al.
Advanced Therapeutics|September 24, 2019
Decellularized Extracellular Matrix Hydrogels as a Delivery Platform for MicroRNA and Extracellular Vesicle TherapeuticsMelissa J Hernandez, Roberto Gaetani, Vera M Pieters, et al.
Plos One|January 1, 2020
Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failurePatricia van den Hoogen, Saskia C A de Jager, Emma A Mol, et al.
Frontiers in Cardiovascular Medicine|May 14, 2019
Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac FibrosisTom C L Bracco Gartner, Janine C Deddens, Emma A Mol, et al.
Advanced Healthcare Materials|August 30, 2016
Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRINKrijn R Vrijsen, Janita A Maring, Steven A J Chamuleau, et al.
Pageof 1